Market cap
₹56 Cr
Revenue (TTM)
₹213 Cr
P/E Ratio
12.1
P/B Ratio
0.6
Div. Yield
0 %
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
56 | 12,143 | 560 | 94 | 39 |
Revenue (₹ Cr) |
213 | 10,474 | 1,718 | 90 | 1 |
Net Profit (₹ Cr) |
4.66 | 384.15 | 46.43 | 3.59 | -0.40 |
Net Margin (%) |
2.18 | 3.63 | 2.68 | 3.96 | -40.89 |
RoE (%) |
5.10 | 24.56 | 13.15 | 6.13 | -- |
Price to Earnings |
12.05 | 27.18 | 12.06 | 26.16 | -- |
Price-To-Book |
0.59 | 5.68 | 1.60 | 1.56 | 1.72 |
Income Statement (₹ Cr)
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
|
Operating Revenue
|
212.73 | 10,473.61 | 1,718.16 | 89.58 | 0.85 |
|
Total Income
|
213.79 | 10,582.34 | 1,732.44 | 90.80 | 0.97 |
|
Total Expenditure
|
203.49 | 9,639.56 | 1,658.60 | 84.97 | 1.24 |
|
EBITDA
|
9.24 | 834.05 | 59.55 | 4.60 | -0.39 |
|
Depreciation
|
2.68 | 227.64 | 8.30 | 0.22 | 0.00 |
|
EBIT
|
6.56 | 606.41 | 51.26 | 4.38 | -0.39 |
|
Interest
|
1.02 | 132.57 | 2.62 | 0.75 | 0.00 |
|
Other Income
|
1.06 | 108.73 | 14.29 | 1.23 | 0.12 |
|
Exceptional Items
|
0.00 | -30.44 | 0.47 | 0.00 | 0.00 |
|
Profit before Tax
|
6.60 | 552.13 | 63.40 | 4.85 | -0.28 |
|
Provision for Tax
|
1.94 | 167.98 | 16.97 | 1.26 | 0.12 |
|
Profit after Tax
|
4.66 | 384.15 | 46.43 | 3.59 | -0.40 |
Liabilities (₹ Cr)
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
91.62 | 2,032.08 | 349.50 | 59.34 | 15.41 |
|
Minority Interest
|
0.00 | 22.10 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
1.71 | 1,077.70 | 23.95 | 1.02 | 0.00 |
|
Current Liabilities
|
31.57 | 2,928.83 | 41.53 | 11.90 | 0.20 |
|
Total Liabilities
|
120.37 | 6,160.85 | 414.98 | 72.25 | 15.61 |
Assets (₹ Cr)
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
32.71 | 2,894.61 | 62.88 | 11.15 | 0.15 |
|
Current Assets
|
74.47 | 2,758.50 | 349.72 | 60.54 | 15.46 |
|
Total Assets
|
120.37 | 6,160.85 | 414.98 | 72.25 | 15.61 |
|
Total Debt*
|
17.76 | 1,468.43 | 24.87 | 10.10 | 0.00 |
|
Net Current Assets
|
42.90 | -170.33 | 308.19 | 48.64 | 15.26 |
|
Contingent Liabilities
|
-- | 164.76 | 1.86 | 0.05 | -- |
Cashflow (₹ Cr)
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-5.73 | 1,281.17 | 53.52 | -1.30 | 0.00 |
|
Cash Flow from Investing Activities
|
-15.77 | -150.39 | -8.92 | -2.95 | -- |
|
Cash from Financing Activities
|
15.09 | -868.90 | -33.22 | -0.18 | 0.00 |
|
Net Cash Inflow / Outflow
|
-6.41 | 261.88 | 11.38 | -4.43 | 0.00 |
Ratios
Profitability Ratios
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
|
ROCE (%)
|
6.53 | 20.95 | 33.62 | 8.94 | 2.84 |
|
ROE (%)
|
5.10 | 24.56 | 13.15 | 6.13 | 2.09 |
|
ROA (%)
|
4.15 | 6.57 | 12.03 | 5.18 | -2.55 |
|
EBIT Margin (%)
|
3.09 | 5.79 | 2.98 | 4.89 | -46.02 |
|
Net Margin (%)
|
2.18 | 3.63 | 2.68 | 3.96 | -40.89 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
76.83 | 8.58 | 5.14 | 38.88 | -60.44 |
|
EBIT Growth (%)
|
181.11 | -3.80 | -62.97 | -13.77 | -159.28 |
|
Net Profit Growth (%)
|
27.00 | 3.76 | -58.35 | -12.13 | -156.63 |
|
EPS Growth (%)
|
27.00 | 3.67 | -95.80 | -44.00 | -152.06 |
|
Book Value Growth (%)
|
3.69 | -14.87 | 17.78 | 6.21 | 2.11 |
Valuation Ratios
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
|
Price / Earnings
|
11.46 | 25.72 | 12.15 | 13.08 | -48.18 |
|
Price / Book Value
|
0.59 | 5.68 | 1.60 | 1.56 | 1.72 |
|
Dividend Yield (%)
|
0.00 | 1.74 | 7.14 | 0.00 | 0.00 |
|
EV/EBITDA
|
7.96 | 15.95 | 6.64 | 20.37 | -100.95 |
|
Market Cap (₹ Cr)
|
66.15 | 10,276.68 | 564.14 | 115.67 | 15.29 |
Solvency Ratios
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.02 | 0.40 | 0.05 | 0.02 | 0.00 |
|
Short term debt to equity ratio
|
0.18 | 0.19 | 0.00 | 0.15 | -- |
|
Current Ratio
|
2.36 | 0.94 | 8.42 | 5.09 | 77.30 |
|
Quick Ratio
|
1.03 | 0.48 | 4.97 | 3.90 | 43.45 |
|
Interest Coverage
|
7.47 | 5.16 | 25.24 | 7.46 | -92.00 |
Operating Efficiency Ratios
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
7.78 | 6.42 | 0.06 | 39.49 | 460.54 |
|
Asset Turnover
|
1.89 | 1.79 | 4.45 | 1.29 | 0.05 |
|
Receivable days
|
34.07 | 21.15 | 0.29 | 126.71 | 561.48 |
|
Inventory Days
|
63.48 | 44.46 | 27.72 | 87.41 | 1,011.41 |
|
Payable days
|
15.31 | 31.76 | 2.46 | 3.90 | 28.80 |
|
Cash Conversion Cycle
|
82.25 | 33.86 | 25.54 | 210.22 | 1,544.08 |